Health care in America is far too expensive; reform will require sacrifices from doctors, hospitals, lawyers, patients, and insurance companies.
American physicians-indeed, all participants in the US health-care system-have been trained and have practiced their profession during the most massive transfer of resources into a single sector, health care, than any society has seen outside war." -Richard Lamm.1
US health-care spending is unsustainable
One could argue that if the American people want to spend a fifth of their wealth on health care, why shouldn't they? There are two problems with this line of reasoning:
1. None of our industrial competitors burden their economies or industries with such costs; and
2. We are not getting our money's worth.
In 1980, the United States had the highest level of health-care spending per capita in the world. Over the next 25 years, the share of GDP devoted to health care in the US has grown from 8.8% in 1980 to just over 16% in 2007. More than a third of these costs were borne by US companies who provide insurance for 60% of the population. By contrast, given their nations' national health systems, virtually none of our foreign industrial competitors are so burdened. And while we now spend 50% to 100% more than other industrialized nations on health care, we rank 37th (behind Costa Rica) in terms of the performance of our health-care delivery system, according to the World Health Organization.2 The WHO's assessment is based on five indicators: overall population health, health disparities, health system responsiveness (i.e., patient satisfaction and how well the system performs), universal access, and financial burden. We badly lag in each category.
Chemoattractants in fetal membranes enhance leukocyte migration near term pregnancy
November 22nd 2024A recent study highlights the release of chemoattractants from human fetal membranes at term, driving leukocyte activation and migration, with implications for labor and postpartum recovery.
Read More
Reproductive genetic carrier screening: A tool for reproductive decision-making
November 22nd 2024A new study highlights the efficacy of couple-based reproductive genetic carrier screening in improving reproductive decisions and outcomes, emphasizing its growing availability and acceptance among diverse populations.
Read More
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More